Process for Making CGRP Receptor Antagonists
US-2016130273-A1 · May 12, 2016 · US
US9487523B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9487523-B2 |
| Application number | US-201314384624-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 13, 2013 |
| Priority date | Mar 14, 2012 |
| Publication date | Nov 8, 2016 |
| Grant date | Nov 8, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention encompasses a novel process for making piperidinone carboxamide indane and azainane derivatives, which are CGRP receptor antagonists useful for the treatment of migraine, utilizing a highly effective spiroacid synthesis.
Opening claim text (preview).
What is claimed is: 1. A process for making a compound of Formula I or a pharmaceutically acceptable salt thereof, wherein: X is selected from —C(R 3 )═, wherein R 3 is hydrogen, F or CN; Y is N; R 1 is selected from the group consisting of: C 1-4 alkyl, cyclopropylmethyl, cyclobutylmethyl and [1-(trifluoromethyl)cyclopropyl]methyl, each of which…
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.